News & Insight

News
A network approach reveals roles for cancer stem cells in cancer promotion
Q&A with Professor Allan Balmain and Dr Mark Taylor on new findings from the PROMINENT team, tackling our Normal Phenotypes challenge
We talked to team PROMINENT members Professor Allan Balmain and Dr Mark Taylor from the University of California San Francisco about their latest paper ‘Stem-cell states converge in multi-stage cutaneous squamous cell carcinoma development…
Read the full article

Latest

News
Global team uncovers genomic secrets behind varied incidence in kidney cancer rates
In a landmark paper published today (1 May, 2024) by the Mutographs team in Nature, they identify new mutational signatures at play in the…
News
Five new teams selected to take on cancer’s toughest challenges
Today we’re excited to announce the five new global teams that have been selected to each receive up to $25m in Cancer Grand Challenges funding over…
Blog
Embedding patient advocacy within a discovery science initiative
As we look towards announcing our new teams on 6 March, we reflect with former members of the Cancer Grand Challenges Advocacy Panel on the role the…
Blog
A holistic approach to cancer research: bringing future research leaders together with patient advocates
Last month we held our annual Future Leaders Conference in Lisbon. As well as being a time for early career researchers from across our funded teams…

News and insight archive

Format
Choose
Team
Choose
Tags
Choose
Q&A with Professor Allan Balmain and Dr Mark Taylor on new findings from the PROMINENT team, tackling our Normal Phenotypes challenge
News
A network approach reveals roles for cancer stem cells in cancer promotion
We talked to team PROMINENT members Professor Allan Balmain and Dr Mark Taylor from the University of California San Francisco about their latest paper ‘Stem-cell states converge in multi-stage cutaneous squamous cell…
Gary Hornett in sequencing laboratory, working at Illumina NovaSeq 600 machines
News
Global team uncovers genomic secrets behind varied incidence in kidney cancer rates
In a landmark paper published today (1 May, 2024) by the Mutographs team in Nature, they identify new mutational signatures at play in the development of clear cell renal cell carcinoma, of unknown origin, which…
Announcing five new global Cancer Grand Challenges teams. Each team will be awarded up to $25m over five years to take on cancer's toughest problems.
News
Five new teams selected to take on cancer’s toughest challenges
Today we’re excited to announce the five new global teams that have been selected to each receive up to $25m in Cancer Grand Challenges funding over five years to take on four of cancer’s toughest challenges. In March…
Current and former members of the Cancer Grand Challenges Advocacy Panel speaking at events and meetings.
Blog
Embedding patient advocacy within a discovery science initiative
As we look towards announcing our new teams on 6 March, we reflect with former members of the Cancer Grand Challenges Advocacy Panel on the role the panel plays in ensuring that the voice of people affected by cancer is…
Future research leaders coming together with patient advocates.
Blog
A holistic approach to cancer research: bringing future research leaders together with patient advocates
Last month we held our annual Future Leaders Conference in Lisbon. As well as being a time for early career researchers from across our funded teams to come together, network and share their scientific findings, this…
A radiographer examining a mammogram image
News
Changing the narrative around ductal carcinoma in situ and breast cancer risk
New findings from the Cancer Grand Challenges PRECISION team this Breast Cancer Awareness Month show that breast cancer development from DCIS is a rare event and emphasise the urgent need for accurate prognostic markers…
Branded graphic with copy: Announcing a new €10m partnership between Cancer Research UK and France’s Institut National Du Cancer
News
Major new scientific partnership between the UK and France to tackle cancer’s toughest challenges
Today we’re announcing a major new €10m (£8.6m) partnership between Cancer Research UK and France’s Institut National Du Cancer (INCa) to help fund world-class researchers to take on cancer’s toughest challenges through…
Announcing the shortlist for the Cancer Grand Challenges awards. 12 teams competing for up to $25m each in funding.
News
Announcing the global teams that have been shortlisted for a Cancer Grand Challenges award
Today, we are excited to reveal the 12 shortlisted teams who are in with a chance of securing up to $25m in Cancer Grand Challenges funding to make radical progress against some of cancer’s toughest challenges.  In…
Q and A with Dr Johan Vande Voorde on new findings from the Rosetta team
News
The power of combining mass spectrometry techniques to interrogate the cancer metabolome
New research from the Cancer Grand Challenges Rosetta team shows that metabolic profiling using a variety of mass spectrometry techniques can be used to stratify tissues according to their underlying mutations in…